RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 69 filers reported holding RAPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $40,221 | -66.2% | 4,479 | -6.4% | 0.02% | -72.4% |
Q4 2023 | $118,957 | +52.6% | 4,787 | +2.0% | 0.08% | +61.7% |
Q3 2023 | $77,964 | -19.1% | 4,691 | -9.0% | 0.05% | -17.5% |
Q2 2023 | $96,361 | -4.6% | 5,153 | -6.4% | 0.06% | +1.8% |
Q1 2023 | $100,980 | -33.1% | 5,503 | -27.8% | 0.06% | -29.1% |
Q4 2022 | $150,975 | -10.7% | 7,625 | +8.7% | 0.08% | +17.9% |
Q3 2022 | $169,000 | +33.1% | 7,015 | +0.7% | 0.07% | +42.6% |
Q2 2022 | $127,000 | +13.4% | 6,964 | +37.0% | 0.05% | -6.0% |
Q1 2022 | $112,000 | -43.4% | 5,082 | -5.7% | 0.05% | -33.3% |
Q4 2021 | $198,000 | +20.0% | 5,389 | +1.4% | 0.08% | +2.7% |
Q3 2021 | $165,000 | -7.3% | 5,312 | -5.0% | 0.07% | 0.0% |
Q2 2021 | $178,000 | -35.3% | 5,589 | -54.9% | 0.07% | -37.1% |
Q1 2021 | $275,000 | +14.6% | 12,381 | +1.9% | 0.12% | +16.0% |
Q4 2020 | $240,000 | -47.9% | 12,155 | -15.1% | 0.10% | -58.7% |
Q3 2020 | $461,000 | -2.3% | 14,317 | -12.0% | 0.24% | +8.0% |
Q2 2020 | $472,000 | – | 16,274 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $49,662,000 | 44.09% |
KPCB XV Associates, LLC | 1,297,063 | $40,274,000 | 30.08% |
Euclidean Capital LLC | 635,177 | $19,722,000 | 9.59% |
Ponoi II Management, LLC | 145,401 | $4,515,000 | 6.69% |
Column Group LLC | 1,402,008 | $43,532,000 | 4.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $35,655,000 | 4.34% |
Trustees of Columbia University in the City of New York | 73,383 | $2,279,000 | 3.48% |
Ghost Tree Capital, LLC | 250,000 | $7,763,000 | 2.27% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 608,663 | $18,899,000 | 2.22% |
AJU IB Investment Co., Ltd. | 99,503 | $3,090,000 | 1.99% |